Proteomics of the human brain: Sub-proteomes might hold the key to handle brain complexity

Journal of Neural Transmission

Volumn 113, Issue 8, 2006, Pages 1041-1054

  Tribl, F ^a,b,c   Marcus, K ^b   Bringmann, G ^c   Meyer, H E ^b   Gerlach, M ^c   Riederer, P ^a,c  

^a National Parkinson Foundation   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Human brain; Lysosome related; Mass spectrometry; Neuromelanin; Proteomics; Sub proteomes; Subcellular

Indexed keywords

BRAIN PROTEIN; NEUROMELANIN; PROTEOME;

AUTOPSY; BIOMEDICINE; BRAIN; BRAIN FUNCTION; BRAIN TISSUE; CELL FRACTIONATION; CELL ORGANELLE; GENOMICS; HUMAN; IMMUNOPRECIPITATION; LYSOSOME; METHODOLOGY; PATHOLOGY; PIGMENTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; REVIEW;

BRAIN CHEMISTRY; CELL FRACTIONATION; HUMANS; MASS SPECTROMETRY; NEURONS; ORGANELLES; PROTEOMICS;

EID: 33746102556     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0513-7     Document Type: Review

References (108)

1. R Aebersold DR Goodlett 2001 Mass spectrometry in proteomics Chem Rev 101 269 295
2. R Aebersold M Mann 2003 Mass spectrometry-based proteomics Nature 422 198 207
3. RD Bagshaw DJ Mahuran JW Callahan 2005 A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle Mol Cell Proteomics 4 133 143
4. V Basrur F Yang T Kushimoto Y Higashimoto K Yasumoto J Valencia J Muller WD Vieira H Watabe J Shabanowitz VJ Hearing DF Hunt E Appella 2003 Proteomic analysis of early melanosomes: identification of novel melanosomal proteins J Proteome Res 2 69 79
5. M Basso S Giraudo D Corpillo B Bergamasco L Lopiano M Fasano 2004 Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 4 3943 3952
6. D Ben-Shachar P Riederer MB Youdim 1991 Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease J Neurochem 57 1609 1614
7. SB Berman TG Hastings 1999 Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1127 1137
8. PA Binz DF Hochstrasser RD Appel 2003 Mass spectrometry-based proteomics: current status and potential use in clinical chemistry Clin Chem Lab Med 41 1540 1551
9. A Björklund O Lindvall 1984 Dopamine-containing systems in the CNS. Handbook of chemical neuroanatomy A Björklund T Hökfelt Classical Transmitters in the CNS, Part I 2 Elsevier Science Publishers Amsterdam 55 122
10. H Braak E Braak 1986 Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult Hum Neurobiol 5 71 82
11. C Buesa T Maes F Subirada M Barrachina I Ferrer 2004 DNA chip technology in brain banks: confronting a degrading world J Neuropathol Exp Neurol 63 1003 1014
12. DA Butterfield A Castegna 2003 Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration Cell Mol Biol (Noisy-le-grand) 49 747 751
13. A Castegna V Thongboonkerd JB Klein B Lynn WR Markesbery DA Butterfield 2003 Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 1394 1401
14. G Chambers L Lawrie P Cash GI Murray 2000 Proteomics: a new approach to the study of disease J Pathol 192 280 288
15. J Choudhary SG Grant 2004 Proteomics in postgenomic neuroscience: the end of the beginning Nat Neurosci 7 440 445
16. HD Coughenour RS Spaulding CM Thompson 2004 The synaptic vesicle proteome: a comparative study in membrane protein identification Proteomics 4 3141 3155
17. C D'Ambrosio S Arena G Fulcoli MH Scheinfeld D Zhou L D'Adamio A Scaloni 2006 Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease Mol Cell Proteomics 5 97 113
18. P Davidsson A Brinkmalm G Karlsson R Persson M Lindbjer M Puchades S Folkesson L Paulson A Dahl L Rymo J Silberring R Ekman K Blennow 2003 Clinical mass spectrometry in neuroscience. Proteomics and peptidomics Cell Mol Biol (Noisy-le-grand) 49 681 688
19. DT Dexter FR Wells F Agid Y Agid AJ Lees P Jenner CD Marsden 1987 Increased nigral iron content in postmortem parkinsonian brain Lancet 2 1219 1220
20. PR Dodd JW Hambley RF Cowburn JA Hardy 1988 A comparison of methodologies for the study of functional transmitter neurochemistry in human brain J Neurochem 50 1333 1345
21. PF Edgar JE Douglas GJ Cooper B Dean R Kydd RL Faull 2000 Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia Mol Psychiatry 5 85 90
22. PF Edgar JE Douglas C Knight GJ Cooper RL Faull R Kydd 1999a Proteome map of the human hippocampus Hippocampus 9 644 650
23. PF Edgar SJ Schonberger B Dean RL Faull R Kydd GJ Cooper 1999b A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals Mol Psychiatry 4 173 178
24. CD Farr PR Gafken AD Norbeck CE Doneanu MD Stapels DF Barofsky M Minami JA Saugstad 2004 Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents J Neurochem 91 438 450
25. Fedorow H, Halliday GM, Rickert CH, Gerlach M, Riederer P, Double KL (2005a) Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging
26. H Fedorow F Tribl G Halliday M Gerlach P Riederer KL Double 2005b Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease Prog Neurobiol 75 109 124
27. M Fountoulakis 2004 Application of proteomics technologies in the investigation of the brain Mass Spectrom Rev 23 231 258
28. M Fountoulakis N Cairns G Lubec 1999 Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome J Neural Transm [Suppl] 57 323 335
29. M Fountoulakis R Hardmeier H Hoger G Lubec 2001 Postmortem changes in the level of brain proteins Exp Neurol 167 86 94
30. J Garin R Diez S Kieffer JF Dermine S Duclos E Gagnon R Sadoul C Rondeau M Desjardins 2001 The phagosome proteome: insight into phagosome functions J Cell Biol 152 165 180
31. M Gerlach P Riederer 1996 Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J Neural Transm 103 987 1041
32. C Gomez-Santos I Ferrer AF Santidrian M Barrachina J Gil S Ambrosio 2003 Dopamine induces autophagic cell death and alpha-synuclein in crease in human neuroblastoma SH-SY5Y cells J Neurosci Res 73 341 350
33. J Grimm A Mueller F Hefti A Rosenthal 2004 Molecular basis for catecholaminergic neuron diversity Proc Natl Acad Sci USA 101 13891 13896
34. E Grünblatt 2004 The benefits of microarrays as tools for studying neuropsychiatric disorders Drugs Today (Barc) 40 147 156
35. E Grünblatt S Mandel J Jacob-Hirsch S Zeligson N Amariglo G Rechavi J Li R Ravid W Roggendorf P Riederer MB Youdim 2004 Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes J Neural Transm 111 1543 1573
36. SP Gygi B Rist SA Gerber F Turecek MH Gelb R Aebersold 1999a Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat Biotechnol 17 994 999
37. SP Gygi Y Rochon BR Franza R Aebersold 1999b Correlation between protein and mRNA abundance in yeast Mol Cell Biol 19 1720 1730
38. B Herbert 1999 Advances in protein solubilisation for two-dimensional electrophoresis Electrophoresis 20 660 663
39. E Hirsch AM Graybiel YA Agid 1988 Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease Nature 334 345 348
40. LA Huber K Pfaller I Vietor 2003 Organelle proteomics: implications for subcellular fractionation in proteomics Circ Res 92 962 968
41. MR Hynd JM Lewohl HL Scott PR Dodd 2003 Biochemical and molecular studies using human autopsy brain tissue J Neurochem 85 543 562
42. K Jellinger E Kienzl G Rumpelmair P Riederer H Stachelberger D Ben-Shachar MB Youdim 1992 Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis J Neurochem 59 1168 1171
43. CR Jimenez FJ Stam KW Li Y Gouwenberg MP Hornshaw F De Winter J Verhaagen AB Smit 2005 Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration Mol Cell Proteomics 4 120 132
44. NL Johnston-Wilson CD Sims JP Hofmann L Anderson AD Shore EF Torrey RH Yolken 2000 Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium Mol Psychiatry 5 142 149
45. BA Jordan BD Fernholz M Boussac C Xu G Grigorean EB Ziff TA Neubert 2004 Identification and verification of novel rodent postsynaptic density proteins Mol Cell Proteomics 3 857 871
46. E Jung M Heller JC Sanchez DF Hochstrasser 2000 Proteomics meets cell biology: the establishment of subcellular proteomes Electrophoresis 21 3369 3377
47. Kaindl AM, Sifringer M, Zabel C, Nebrich G, Wacker MA, Felderhoff-Mueser U, Endesfelder S, von der Hagen M, Stefovska V, Klose J, Ikonomidou C (2005) Acute and long-term proteome changes induced by oxidative stress in the developing brain. Cell Death Differ. [Epub ahead of print]
48. K Kanninen G Goldsteins S Auriola I Alafuzoff J Koistinaho 2004 Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach Neurosci Lett 367 235 240
49. A Kastner EC Hirsch O Lejeune F Javoy-Agid O Rascol Y Agid 1992 Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem 59 1080 1089
50. Kellner R, Lottspeich F, Meyer HE (1999) Microcharacterization of Proteins, Wiley-VCH
51. J Klose 1975 Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals Humangenetik 26 231 243
52. J Klose 1999a Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis Methods Mol Biol 112 67 85
53. J Klose 1999b Large-gel 2-D electrophoresis Methods Mol Biol 112 147 172
54. J Klose C Nock M Herrmann K Stuhler K Marcus M Bluggel E Krause LC Schalkwyk S Rastan SD Brown K Bussow H Himmelbauer H Lehrach 2002 Genetic analysis of the mouse brain proteome Nat Genet 30 385 393
55. MA Korolainen G Goldsteins I Alafuzoff J Koistinaho T Pirttila 2002 Proteomic analysis of protein oxidation in Alzheimer's disease brain Electrophoresis 23 3428 3433
56. K Krapfenbauer E Engidawork N Cairns M Fountoulakis G Lubec 2003 Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders Brain Res 967 152 160
57. H Langen P Berndt D Roder N Cairns G Lubec M Fountoulakis 1999 Two-dimensional map of human brain proteins Electrophoresis 20 907 916
58. MR Larsen P Roepstorff 2000 Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis Fresenius J Anal Chem 366 677 690
59. KW Li MP Hornshaw J van Minnen KH Smalla ED Gundelfinger AB Smit 2005 Organelle Proteomics of Rat Synaptic Proteins: Correlation-Profiling by Isotope-Coded Affinity Tagging in Conjunction with Liquid Chromatography-Tandem Mass Spectrometry to Reveal Post-synaptic Density Specific Proteins J Proteome Res 4 725 733
60. G Lominadze DW Powell GC Luerman AJ Link RA Ward KR [tmp] McLeish 2005 Proteomic Analysis of Human Neutrophil Granules Mol Cell Proteomics 4 1503 1521
61. F Lottspeich 1999 Proteome analysis: a pathway to the functional analysis of proteins Angew Chem Int Ed Engl 38 2476 2492
62. A Lüking DJ Cahill S Mullner 2005 Protein biochips: a new and versatile platform technology for molecular medicine Drug Discov Today 10 789 794
63. DM Mann PO Yates 1983 Possible role of neuromelanin in the pathogenesis of Parkinson's disease Mech Ageing Dev 21 193 203
64. ER Marcotte DM Pearson LK Srivastava 2001 Animal models of schizophrenia: a critical review J Psychiatry Neurosci 26 395 410
65. ER Marcotte LK Srivastava R Quirion 2003 cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease Pharmacol Ther 100 63 74
66. K Marcus O Schmidt H Schäfer M Hamacher A Van Hall HE Meyer 2004 Proteomics-application to the brain Int Rev Neurobiol 61 285 311
67. CD Marsden 1961 Pigmentation in the nucleus substantiae nigrae of mammals J Anat 95 256 261
68. CD Marsden 1983 Neuromelanin and Parkinson's disease J Neural Transm [Suppl] 19 121 141
69. DA [tmp] McRitchie GM Halliday H Cartwright 1995 Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human Neuroscience 68 539 551
70. HE Meyer E Hoffmann-Posorske H Korte LM Heilmeyer Jr 1986 Sequence analysis of phosphoserine-containing peptides. Modification for picomolar sensitivity FEBS Lett 204 61 66
71. ML Mimmack J Brooking S Bahn 2004 Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies Biol Psychiatry 55 337 345
72. Y Mizuno S Ohta M Tanaka S Takamiya K Suzuki T Sato H Oya T Ozawa Y Kagawa 1989 Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease Biochem Biophys Res Commun 163 1450 1455
73. L Mouledous S Hunt R Harcourt J Harry KL Williams HB Gutstein 2003a Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples Proteomics 3 610 615
74. L Mouledous S Hunt R Harcourt JL Harry KL Williams HB Gutstein 2003b Proteomic analysis of immunostained, laser-capture microdissected brain samples Electrophoresis 24 296 302
75. PH O'Farrell 1975 High resolution two-dimensional electrophoresis of proteins J Biol Chem 250 4007 4021
76. S-E Ong M Mann 2005 Mass spectrometry-based proteomics turns quantitative Nature Chem Biol 1 252 262
77. SR Owens H Breithaupt 2002 From genomes to cures-a long way to go. More than a year after the publication of the first draft of the human genome, scientists took stock of its implications for science and society EMBO Rep 3 11 14
78. JJ Palacino D Sagi MS Goldberg S Krauss C Motz M Wacker J Klose J Shen 2004 Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J Biol Chem 279 18614 18622
79. L Paulson R Persson G Karlsson J Silberring A Bierczynska-Krzysik R Ekman A Westman-Brinkmalm 2005 Proteomics and peptidomics in neuroscience. Experience of capabilities and limitations in a neurochemical laboratory J Mass Spectrom 40 202 213
80. E Perlson KF Medzihradszky Z Darula DW Munno NI Syed AL Burlingame M Fainzilber 2004 Differential proteomics reveals multiple components in retrogradely transported axoplasm after nerve injury Mol Cell Proteomics 3 510 520
81. TM Preuss M Caceres MC Oldham DH Geschwind 2004 Human brain evolution: insights from microarrays Nat Rev Genet 5 850 860
82. Reichmann H, Riederer P (1989) Biochemical analyses of respiratory chain enzymes in different brain regions of patients with Parkinson's disease. BMBF Symposium "Morbus Parkinson und andere Basalganglienerkrankungen", Bad Kissingen, Abstract 1989, S44
83. P Riederer WD Rausch B Schmidt P Kruzik C Konradi E Sofic W Danielczyk M Fischer E Ogris 1988 Biochemical fundamentals of Parkinson's disease Mt Sinai J Med 55 21 28
84. P Riederer E Sofic WD Rausch P Kruzik MBH Youdim 1985 Dopaminforschung heute und morgen - L-Dopa in der Zukunft H Umek L-Dopa-Substitution der Parkinson-Krankheit: Geschichte - Gegenwart - Zukunft Springer Wien New York 127 144
85. MM Ryan SJ Huffaker MJ Webster M Wayland T Freeman S Bahn 2004 Application and optimization of microarray technologies for human postmortem brain studies Biol Psychiatry 55 329 336
86. V Santoni M Molloy T Rabilloud 2000 Membrane proteins and proteomics: un amour impossible? Electrophoresis 21 1054 1070
87. AH Schapira JM Cooper D Dexter P Jenner JB Clark CD Marsden 1989 Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1269
88. B Schilling MMS Bharath RH Row J Murray MP Cusack RA Capaldi CR Freed KN Prasad JK Andersen BW Gibson 2005 Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line Mol Cell Proteomics 4 84 96
89. SJ Schonberger PF Edgar R Kydd RL Faull GJ Cooper 2001 Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process Proteomics 1 1519 1528
90. M Shamoto-Nagai W Maruyama Y Akao T Osawa F Tribl M Gerlach FA Zucca L Zecca P Riederer M Naoi 2004 Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells J Neural Transm 111 1253 1265
91. B Sitek J Luttges K Marcus G Kloppel W Schmiegel HE Meyer SA Hahn K Stuhler 2005 Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma Proteomics 5 2665 2679
92. J Smythies 1996 On the functional of neuromelanin Proc R Soc Lond B Biol Sci 263 487 489
93. DG Standaert 2005 Applications of laser capture microdissection in the study of neurodegenerative disease Arch Neurol 62 203 205
94. D Sulzer J Bogulavsky KE Larsen G Behr E Karatekin MH Kleinman N Turro D Krantz RH Edwards LA Greene L Zecca 2000 Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles Proc Natl Acad Sci USA 97 11869 11874
95. SW Taylor E Fahy SS Ghosh 2003 Global organellar proteomics Trends Biotechnol 21 82 88
96. F Tribl M Gerlach K Marcus E Asan T Tatschner T Arzberger HE Meyer G Bringmann P Riederer 2005 "Subcellular Proteomics" of Neuromelanin Granules Isolated from the Human Brain Mol Cell Proteomics 4 945 957
97. JC Trinidad A Thalhammer CG Specht R Schoepfer AL Burlingame 2005 Phosphorylation state of postsynaptic density proteins J Neurochem 92 1306 1316
98. M Unlu ME Morgan JS Minden 1997 Difference gel electrophoresis: a single gel method for detecting changes in protein extracts Electrophoresis 18 2071 2077
99. Van Deerlin VMD, Ginsberg SD, Lee VM-Y, Trojanowski JQ (2002) The use of fixed human post mortem brain tissue tu study mRNA expression in neurodegenerative diseases: application of microdissection and mRNA amplification. Microarrays for the neurosciences: an essential guide. Gregg JP (ed) Cambridge, Massachusetts, MIT press: 201-235
100. H Voshol MJ Glucksman J van Oostrum 2003 Proteomics in the discovery of new therapeutic targets for psychiatric disease Curr Mol Med 3 447 458
101. VP Whittaker MN Sheridan 1965 The morphology and acetylcholine content of isolated cerebral cortical synaptic vesicles J Neurochem 12 363 372
102. DA Wolters MP Washburn JR Yates 3rd 2001 An automated multidimensional protein identification technology for shotgun proteomics Anal Chem 73 5683 5690
103. CC Wu JR Yates 3rd 2003 The application of mass spectrometry to membrane proteomics Nat Biotechnol 21 262 267
104. LR Yu TP Conrads T Uo Y Kinoshita RS Morrison DA Lucas KC Chan J Blonder HJ Issaq TD Veenstra 2004 Global analysis of the cortical neuron proteome Mol Cell Proteomics 3 896 907
105. X Yuan DM Desiderio 2005 Proteomics analysis of human cerebrospinal fluid J Chromatogr B Analyt Technol Biomed Life Sci 815 179 189
106. C Zabel DC Chamrad J Priller B Woodman HE Meyer GP Bates J Klose 2002 Alterations in the mouse and human proteome caused by Huntington's disease Mol Cell Proteomics 1 366 375
107. C Zabel J Klose 2004 Influence of Huntington's disease on the human and mouse proteome Int Rev Neurobiol 61 241 283
108. Y Zhou G Gu DR Goodlett T Zhang C Pan TJ Montine KS Montine RH Aebersold J Zhang 2004 Analysis of alpha-synuclein-associated proteins by quantitative proteomics J Biol Chem 279 39155 39164